At the end of the day, Dr. Catherine Klapperich, Director of the Center for Future Technologies in Cancer Care, a Kern Innovation Faculty Fellow, an Associate Professor of Biomedical Engineering, Director of the Laboratory for Diagnostics and Global Healthcare Technologies, and a member of the Center for Nanoscience and Nanotechnology at Boston University, sat down to tell us more about the Center.
The finals were an incredible mix of technology and innovation that was very impressive.
Most interesting was the brilliant women who proposed screening for cervical cancer with a tampon rather than a pap smear. Imagine that?! Instead of driving 40 minutes to the doctor, sitting in the waiting room for 45 minutes, spending 10 minutes on an uncomfortable exam table in stirrups, and then nervously waiting 7-10 days for the results, you can screen for cervical cancer in the comfort of your own bathroom. You would take a used tampon, dip it in a reagent, and watch for a color change that could then transmit the results to a treating physician. Fantastic!
In terms of immediately useful to patients and most easily marketable, Team Ian Butterworth, M+Vision Research Fellow, Nicholas Woolf, Boston University School of Medicine MD/PhD candidate, and Andrew Brown with MIT propose creating a mouthwash or a Popsicle that prevents the metallic taste that patients often experience with chemotherapy. This often prevents patients from eating enough nutrition, which in turns, leads to weight loss and morbidity.
Nicholas Woolf and Ian Butterworth demonstrating a mouthwash that could make food taste better to chemotherapy patients
Andrew Brown showing already marketed technology that makes food taste better
Andrew Brown holding their 3D printed Popcicle
Dominic Surrao, Web Applications Architect at Massachusetts General Hospital Lab of Computer Science, with Srinivasan Krishnamoorthy, PhD, Research Assistant Professor in Biology and Biochemistry at University of Houston propose using peptide microarray technology to detect cardiotoxicity secondary to Doxorubicin and other chemotheraputic drugs.
My passion is healthcare optimization, whether that is with innovation, making scientific discoveries, or improving delivery. I love bringing people and ideas together and making projects work. With this, medicine exists to improve lives, and I will strive to always help patients and those around me.
Send this to a friend